HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.

類似資料

• HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
  著者:: Wirtz, P, 等
  出版事項: (2005)
• Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
  著者:: Lang, B, 等
  出版事項: (2003)
• Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
  著者:: Maddison, P, 等
  出版事項: (2001)
• Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
  著者:: Titulaer, M, 等
  出版事項: (2010)
• Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
  著者:: Titulaer, M, 等
  出版事項: (2011)